Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing
Jose de Leon
Psychiatry Investig. 2023;20(3):183-195. Published online 2023 Feb 28 DOI: https://doi.org/10.30773/pi.2022.0293
|
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition
Georgios Schoretsanitis, A. Elif Anıl Yağcıoğlu, Can-Jun Ruan, Chin B. Eap, Espen Molden, Trino Baptista, Scott R. Clark, Emilio Fernandez-Egea, Se Hyun Kim, Hsien-Yuan Lane, Jonathan Leung, Olalla Maroñas Amigo, Mariano Motuca, Ismael Olmos, Susanna Ever
Schizophrenia Research.2024; 268: 302. CrossRef Slower clozapine titration than the official Japanese protocol led to fewer inflammatory adverse effects: A retrospective chart review of seven hospitals
Yuki Kikuchi, Hiroshi Komatsu, Yuji Otsuka, Fumiaki Ito, Nobuhisa Kanahara, Hiroaki Tanifuji, Hiroaki Tomita
Schizophrenia Research.2024; 268: 98. CrossRef The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences
Jose de Leon, Linda Wang, George M. Simpson
Schizophrenia Research.2024; 268: 14. CrossRef A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration
Olivia Carswell, Lisa R. Wilton, Kerri Nicholls, Vinod Thomas, Scott R. Clark
Schizophrenia Research.2024; 268: 88. CrossRef A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia
Natalie Kwok Wing Cheuk, Wing Tse, Harry Kam Hung Tsui, Chak Fai Ma, Johnny Siu Wah Chun, Albert Kar Kin Chung, Sherry Kit Wa Chan
Schizophrenia Research.2024; 268: 205. CrossRef An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance
Marina Sagud, Dagmar Breznoscakova, Andreja Celofiga, Jana Chihai, Eka Chkonia, Dragana Ristic Ignjatovic, Lidija Injac Stevovic, Miloslav Kopecek, Katrin Kurvits, Nazar Kuzo, Judit Lazáry, Ramunė Mazaliauskienė, Djurdjica Mladina Perisa, Antoni Novotni,
Schizophrenia Research.2024; 268: 53. CrossRef Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
Renato de Filippis, Carlos De las Cuevas, Emilio J. Sanz, Georgios Schoretsanitis, Christoph U. Correll, Jose de Leon
Schizophrenia Research.2024; 268: 118. CrossRef A Systematic Review of Clozapine Concentration–Dose Ratio from Therapeutic Drug Monitoring Studies in Children and Adolescents Treated with Clozapine for Mental Disorders
Sara Jiménez-Fernández, Manuel Gurpegui, Christoph U. Correll, Jose de Leon, Georgios Schoretsanitis
Therapeutic Drug Monitoring.2024; 46(2): 170. CrossRef Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
Carlos De las Cuevas, Emilio J. Sanz, Jason A. Gross, Christoph U. Correll, Hélène Verdoux, John Lally, Renato de Filippis, Peter F.J. Schulte, Espen Molden, Manuel Arrojo-Romero, Adrian D. Bostrom, Georgios Schoretsanitis, Emilio Fernandez-Egea, Jose de
Schizophrenia Research.2024; 268: 175. CrossRef Promoting safer and wider worldwide use of clozapine
Jose de Leon
Schizophrenia Research.2024;[Epub] CrossRef Can slow personalized titration using C-Reactive Protein monitoring decrease the high rates and mortality of clozapine-associated myocarditis seen in some countries? A call for research
Jose de Leon
Journal of Clinical Psychopharmacology.2024;[Epub] CrossRef Evaluation of major adverse events of clozapine based on accordance to an international titration guideline
Matthew Nuebel, Jonathan G. Leung, Christopher Hughes, Ian McGrane
Mental Health Clinician.2024; 14(3): 204. CrossRef Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
Jose de Leon, Can-Jun Ruan, Georgios Schoretsanitis, Alejandro G. Villasante-Tezanos, Edoardo Spina, Emilio J. Sanz, Moisés Betancort, Carlos De las Cuevas
Expert Opinion on Drug Metabolism & Toxicology.2024; 20(8): 857. CrossRef When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Mishal Qubad, Gabriele Dupont, Martina Hahn, Simon S. Martin, Valentina Puntmann, Eike Nagel, Andreas Reif, Robert A. Bittner
CNS Drugs.2024; 38(9): 671. CrossRef Towards precision dosing in psychiatry: Population pharmacokinetics meta-modelling of clozapine and lithium
Aurélie Lereclus, Julien Welzel, Raoul Belzeaux, Théo Korchia, Frédéric Dayan, Olivier Blin, Sylvain Benito, Romain Guilhaumou
Journal of Psychopharmacology.2024; 38(12): 1054. CrossRef Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
Carlos De las Cuevas, Emilio Sanz, Jose de Leon
Patient Preference and Adherence.2024; Volume 18: 2261. CrossRef Escaping the Long Shadow Cast by Agranulocytosis
Jose de Leon, Manuel Arrojo-Romero, Hélène Verdoux, Can-Jun Ruan, Georgios Schoretsanitis, Christopher Rohde, Dan Cohen, Peter F.J. Schulte, Se Hyun Kim, Robert O. Cotes, Jonathan G. Leung, Yuji Otsuka, Oleg O. Kirilochev, Trino Baptista, Sandeep Grover,
Journal of Clinical Psychopharmacology.2023; 43(3): 239. CrossRef Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients
Can-Jun Ruan, Ismael Olmos, Carina Ricciardi, Georgios Schoretsanitis, Philippe D. Vincent, A. Elif Anıl Yağcıoğlu, Chin B. Eap, Trino Baptista, Scott R. Clark, Emilio Fernandez-Egea, Se Hyun Kim, Hsien-Yuan Lane, Jonathan Leung, Olalla Maroñas Amigo, Mar
Schizophrenia Research.2023;[Epub] CrossRef Will ChatGPT3 Substitute for us as Clozapine Experts?
Jose de Leon, Carlos De Las Cuevas
Journal of Clinical Psychopharmacology.2023; 43(5): 400. CrossRef Transient eosinophilic colitis in clozapine use
Aderonke Oyetunji, Val Bellman, Jianwei Jiao
Psychiatry Research Case Reports.2023; 2(2): 100178. CrossRef
|